Open Access
HOW I DO IT
Photoselective vaporization of the prostate in office and outpatient settings
Brian D. Rosenthal1, Joseph V. DiTrolio2
1
Urological Associates of Montgomery County, East Norriton, Pennsylvania, USA
2
Section of Urology/Department of Surgery UMDNJ/New Jersey Medical School, New Jersey, USA
Address correspondence to Dr. Joseph V. DiTrolio, 556 Eagle
Rock Avenue, Suite 204, Roseland, NJ 07068 USA
Canadian Journal of Urology 2012, 19(2), 6223-6226.
Abstract
The 980 nm/1470 nm diode laser represents the latest in
laser technology for photovaporization of the prostate.
Surgeons have already used this device in both inpatient and
outpatient (office and ASC) setting to produce transurethral
resection of the prostate (TURP) like lesions—albeit
with fewer complications than traditional methods. The
objective of this article is to report the techniques we used
to demonstrate its efficacy and safety of the Evolve Dual
(biolitec Inc., East Longmeadow, MA, USA) system in an
outpatient surgery type setting.
Keywords
photovaporization, benign prostatic hyperplasia, outpatient, 980-nm/1470-nm diode laser, in office
Cite This Article
APA Style
Rosenthal, B.D., DiTrolio, J.V. (2012). Photoselective vaporization of the prostate in office and outpatient settings. Canadian Journal of Urology, 19(2), 6223–6226.
Vancouver Style
Rosenthal BD, DiTrolio JV. Photoselective vaporization of the prostate in office and outpatient settings. Can J Urology. 2012;19(2):6223–6226.
IEEE Style
B.D. Rosenthal and J.V. DiTrolio, “Photoselective vaporization of the prostate in office and outpatient settings,” Can. J. Urology, vol. 19, no. 2, pp. 6223–6226, 2012.
Copyright © 2012 The Canadian Journal of Urology.